Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.109ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
FR.1.5ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
JN.10ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
HK.12ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
HK.33ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
GK.5.1ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XCZORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
FL.40ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
FK.1.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21062.3US
GA.4.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21062.3US
CJ.1.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21062.3US
EP.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21062.3US
B.1.1.381NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21062.3US
BM.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21062.3US
FD.1.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21062.3US
LY.1NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21062.3US
B.1.640NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21047.5US
B.1.640.2NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21047.5US
A.29NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21047.5US
B.1.640.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-21047.5US
B.1.112NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21016.2US
FL.35.1ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-21016.1Japan
XBB.1.25ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-21016.1Japan
GW.5.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
KE.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
KE.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
GW.5.1.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
GW.5.3.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
GW.5.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
GW.5NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
KE.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
GW.5.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-21001.7Germany
GC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
B.1.1.297NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
GW.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
FL.20.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
GJ.1.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
DV.7.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
JR.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
XDENWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
EG.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
XBB.1.5.42NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
GW.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
HY.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
GK.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
HN.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
JY.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-20999.4South Korea
BF.7.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20999.1Germany
XBB.1.5.38ORF1abNIID WH-1 F501R913CTTTACCAGCACGTGCTAGAAGG2352.17896874R-20992.8Japan
XBC.1.4ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-20973.1Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used